HB 2145 prohibits drug manufacturers from restricting how 340B-covered safety net providers (like community health centers, HIV clinics, and tribal health centers) access discounted medications. It specifically bans manufacturers from denying or limiting delivery of 340B drugs to these providers or their contracted pharmacies, and prevents them from requiring data sharing as a condition for drug access. The law allows covered entities to sue violators for up to $5,000 per day per violation and requires penalties for noncompliance. This directly protects low-income patients who rely on affordable medications through Washington's safety net providers.
This bill requires most health insurance plans (excluding public employee plans) to cover intravenous immunoglobulin therapy for children diagnosed with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) or PANS (pediatric acute-onset neuropsychiatric syndrome) starting January 2027. It mandates coverage for three initial monthly treatment courses and ongoing care as medically necessary, after less intensive treatments fail or aren't tolerated. The law prohibits insurers from denying coverage based on prior treatment history, diagnostic name changes, requiring ineffective symptom-only therapies first, or restricting coverage inconsistent with medical guidelines. It also ensures coverage for out-of-state treatment when local care isn't available.
HB 2211 requires Washington state-administered health benefit programs (like Medicaid) to provide medically tailored meals through Washington-based nonprofit vendors when possible. It mandates that meal vendors follow nutrition care plans approved by qualified medical professionals and meet specific standards: meals must align with evidence-based guidelines for medical conditions, offer dietary/cultural accommodations, prioritize locally sourced whole foods, provide at least 500 calories or meet individual energy needs, and deliver one-third of daily recommended carbohydrates and protein. The bill defines "medically tailored meals" as fresh/frozen meals designed by medical professionals to treat specific health conditions. This legislation directly affects state health programs, vendors, and clients with medical conditions requiring specialized nutrition.
SB 5878 requires Washington school districts to offer plant-based meal options at no extra cost when requested by a student, parent, or guardian, beginning in the 2026-27 school year. It defines "plant-based" as USDA-recognized meat alternatives and mandates clear labeling of these options in all meal materials. The law applies to all K-12 public schools, charter schools, and tribal education compact schools, but excludes summer food programs. School districts must honor requests for every meal the student participates in, though they may offer plant-based options to all students regardless of request. This policy change directly affects school meal programs and students seeking alternatives to animal-product-containing meals.
This bill restricts the use of specific nursing titles in Washington State to only licensed professionals. It prohibits anyone without a valid license from using titles like "registered nurse" (R.N.), "nurse practitioner" (N.P.), or "licensed practical nurse" (L.P.N.), including nonhuman entities like businesses. Christian Science nurses listed in their official journal may still use "Christian Science nurse" if they don’t claim other nursing credentials. The law expires June 30, 2027, after taking effect on the same date.
SB 5946 would expand Washington's medical assistance program eligibility to include individuals with income at or below 300% of the federal poverty level (adjusted annually for family size). This change would directly affect low-income residents who currently earn above the existing income threshold but fall within this new range. The bill requires the Health Care Authority to submit a state plan amendment to federal Medicaid authorities by July 1, 2027, to implement this expanded eligibility. The policy change would allow more people to enroll in the state's medical assistance program without altering the program's existing structure.
SB 5947 establishes a 19-member Washington Health Care Board to design a universal health care plan for all state residents. The board must develop the plan, secure federal approval and funding through a waiver, and recommend legislative changes before implementation. It includes specific representation: employers, health providers (like primary care doctors and nurses), tribal leaders, labor, and health financing experts. The bill cannot take effect until federal law permits states to create such a plan with federal funding.
HB 2113 updates Washington State's supervision rules for diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging (MRI) technologists. It allows these professionals to perform certain injections (like IV contrast) under virtual supervision via real-time video (excluding audio-only) or direct supervision by physicians, advanced nurses, or physician assistants. The bill also requires trained clinical staff to be present during IV contrast administration to handle potential adverse reactions. These changes specifically affect technologists working under physician oversight in medical settings.
SB 5917 authorizes Washington's Department of Health to operate a program distributing abortion medications (like mifepristone and misoprostol) to healthcare providers and entities offering reproductive health care, including abortion services. The bill requires medications to be sold at cost - capped at list price plus a $5 fee per dose for secure storage and delivery - and prioritizes bulk distribution to clinics and hospitals. It exempts the state from needing a wholesaler's license for this program under existing law and mandates that medications only be used for reproductive health care. The policy directly affects healthcare providers and facilities that offer abortion or pregnancy-related care in Washington State.
HB 2204 amends Washington State's health technology assessment program to improve how medical technologies (like drugs or devices) are reviewed for coverage in state health programs. It requires the state to prioritize reviewing technologies with Medicare relevance, safety concerns, high costs, or significant usage variations, and mandates systematic evidence-based assessments by federal-designated centers. The bill requires annual reviews of covered technologies (every 18 months), includes public comment periods, and ensures decisions align with federal Medicare guidelines unless new evidence supports a different conclusion. This directly affects Washington's Medicaid programs, healthcare providers, technology manufacturers, and patients by shaping which treatments qualify for state-covered benefits.